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Activation of the c-Jun NH2-terminal kinase (JNK) group of mitogen-activated protein (MAP) kinases is
mediated by a protein kinase cascade. This signaling mechanism may be coordinated by the interaction of
components of the protein kinase cascade with scaffold proteins. The JNK-interacting protein (JIP) group of
scaffold proteins selectively mediates signaling by the mixed-lineage kinase (MLK)3MAP kinase kinase 7
(MKK7)3JNK pathway. The scaffold proteins JIP1 and JIP2 interact to form oligomeric complexes that
accumulate in peripheral cytoplasmic projections extended at the cell surface. The JIP proteins function by
aggregating components of a MAP kinase module (including MLK, MKK7, and JNK) and facilitate signal
transmission by the protein kinase cascade.
The response of cells to extracellular stimuli is mediated by
evolutionarily conserved signaling mechanisms that regulate
proliferation, differentiation, and survival. These mechanisms
include mitogen-activated protein kinase (MAPK) signal
transduction pathways. Several groups of MAPKs have been
identified in yeast, Drosophila melanogaster, and Caenorhabdi-
tis elegans. In mammals, three groups of MAPKs have been
described: the extracellular signal-regulated protein kinases
(ERK), the c-Jun NH2-terminal kinases (JNK), and the p38
MAPKs. Each of these groups of MAPKs is activated by dual
phosphorylation on Thr and Tyr by a MAPK kinase (MAPKK)
which, in turn, is activated by a MAPKK kinase (MAPKKK).
Comparison of ERK, JNK, and p38 MAPKs indicates that the
biological function of each group of MAPKs is different.
The JNK group of MAPKs is activated by treatment of cells
with inflammatory cytokines or by exposure to environmental
stress (11). Activated JNK phosphorylates many cellular pro-
teins, including components of the AP-1 transcription factor
complex (c-Jun and ATF-2). This phosphorylation leads to
increased AP-1 transcription activity (11). The role of in-
creased AP-1 transcription activity is unclear. However, JNK
signaling and AP-1 activation have been implicated in multiple
biological processes (11). For example, genetic analysis of Dro-
sophila demonstrated that JNK is required for early embryonic
morphogenesis (20, 26). Genetic epistasis analysis indicated
that the effect of JNK on morphogenesis is mediated by acti-
vated Drosophila Jun (9, 19, 25). The JNK signaling pathway is
also required for mammalian embryogenesis (6, 14, 17, 34).
Three mammalian genes encode JNK protein kinases. JNK1
and JNK2 are expressed ubiquitously, while JNK3 is expressed
primarily in the brain (2, 7, 12, 15, 24). A role for JNK in
neuronal apoptosis has been demonstrated (31). Recent stud-
ies of knockout mice have confirmed this observation. Tar-
geted disruption of the Jnk3 gene causes defects in stress-
induced neuronal apoptosis (36), while animals lacking both
Jnk1 and Jnk2 genes exhibit defects in developmental neuronal
apoptosis (14). JNK is also required for apoptosis of CD41
CD81 double-positive thymocytes caused by anti-CD3 in vivo
(21, 22). Cellular proliferation, death, and survival may there-
fore be regulated by the JNK signaling pathway in vivo (11).
The JNK signaling pathway also appears to regulate the func-
tion of differentiated cells. For example, disruption of the Jnk1
(4) and Jnk2 (22, 35) genes in mice causes defects in T-cell
function and immune responses. The JNK signaling pathway
therefore contributes to multiple biological processes and rep-
resents an important mechanism that is used by cells to re-
spond to extracellular stimulation (11).
JNK is activated by phosphorylation on Thr and Tyr by
MKK4 and MKK7 (11). These MAPKKs are activated, in turn,
by phosphorylation by MAPKKKs, including ASK1, TPL2,
TAK1, and members of the MEKK and mixed-lineage protein
kinase (MLK) groups of MAPKKKs (11). Biochemical studies
demonstrate that each step in the MAPKKK3MAPKK3JNK
signaling pathway can be reconstituted in vitro. However, it is
unclear whether these assays faithfully mimic the activation of
the JNK pathway in vivo. It is likely that the components of the
JNK protein kinase cascade may be organized into defined
signaling modules (29). For example, the MAPKKK MEKK1
binds to JNK, MKK4, and the Ste20-related protein kinase
NIK (27, 30, 32). These interactions may participate in the
transmission of signals from MEKK1 to JNK by the creation of
a specific signaling module in vivo (29). A functional signaling
module could also be created by the interaction of components
of the JNK signaling pathway with other proteins. An example
is provided by the scaffold protein JNK-interacting protein 1
(JIP1) (3), which binds JNK, MKK7, MLKs, and the Ste20-
related protein kinase HPK1 (28). The JIP1 scaffold mediates
signaling to JNK by members of the MLK group of MAPKKKs
but does not participate in signaling by the MEKK group of
MAPKKKs (28).
The purpose of the study described in this report was to
examine the JIP-mediated JNK signaling module. We demon-
strate that JIP1 is a member of a group of MAPK scaffold
proteins that includes JIP2. Both JIP1 and JIP2 form homo-
and hetero-oligomeric complexes with components of the
JNK signaling pathway. The JIP scaffolds facilitate JNK
activation by MLK protein kinases by aggregating compo-
nents of the MAPK cascade to form a functional JNK sig-
naling module.
* Corresponding author. Mailing address: Howard Hughes Medical
Institute, Program in Molecular Medicine, University of Massachusetts
Medical School, 373 Plantation St., Worcester, MA 01605. Phone:
(508) 856-6054. Fax: (508) 856-3210. E-mail: roger.davis@umassmed
.edu.
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FIG. 1. JIP2 is a member of the JIP group of scaffold proteins. (A) The
structure of the JIP group of scaffold proteins is illustrated schematically. The
JBD, the SH3 domain, and the PTB domain are indicated. Comparison of the
NH2-terminal region of JIP2 (residues 1 to 603) with the corresponding region
of JIP1 indicates 41% identity and 46% similarity (Line-up Program, Wisconsin
package, version 9.1; Genetics Computer Group). The SH3 domains of JIP2
(residues 604 to 665) and JIP1 are 66% identical and 80% similar. The PTB
domains of JIP2 (residues 683 to 812) and JIP1b are 64% identical and 74%
similar. (B) The human JIP2 gene consists of 12 exons and is located on chro-
mosome 22q13 (GenBank accession no. U62317). The structure of the gene is
illustrated schematically. Solid boxes, coding regions; open boxes, noncoding
regions of exons 1 and 12. (C) The primary sequence of human JIP2 deduced
from the sequence of cDNA clones is presented in single-letter code and com-
pared to the sequences of JIP1 and JIP1b. Periods, residues that are identical to
JIP2 residues; dashes, deletions; pound signs (#), termination codons. The JBD,
the SH3 domain, and the PTB domain are indicated. The sequences of JIP1,
JIP1b, and JIP2 have been deposited in GenBank under accession no. AF003115,
AF054611, and AF136382, respectively. (D) The expression of JIP2 mRNA was
examined by Northern blot analysis of different human tissues (Clontech Inc.)
using JIP2 cDNA as a probe. (E) Comparison of the tissue distribution of the
expression of the human JIP1 and JIP2 genes. Immobilized human mRNA was
hybridized with human JIP1 and JIP2 cDNA probes labeled with 32P by random
priming. The data were quantitated by PhosphorImager analysis and are pre-
sented graphically. The data are normalized to the expression in the whole brain
(arbitrarily set at 1.0). JIP1 and JIP2 are represented by open and filled bars,
respectively.
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Molecular cloning of JIP2. JIP2 cDNA clones were isolated from a human
brain lZAPII cDNA library (Stratagene Inc.) by plaque hybridization using a JIP
cDNA fragment as a probe. The largest clone (3,355 bp) included the complete
open reading frame of human JIP2. The sequence of JIP2 was determined by
using an Applied Biosystems 373A machine.
Plasmids. Expression vectors for JIP2 were constructed by using the plasmids
pCDNA3 (Invitrogen Inc.), pEBG (23), and pGEX-4T-1 (Pharmacia-LKB Bio-
technology Inc.) by subcloning PCR fragments of JIP2 in the BamHI/NheI,
BamHI/NotI, and BamHI/NotI sites, respectively. Expression vectors for MAPKs,
MAPKKs, MAPKKKs, JIP1, and JIP1b have been described previously (28).
Antibodies. The antibodies to the Flag epitope tag (M2; Sigma), the hemag-
glutinin (HA) epitope tag (12CA5; Boehringer Mannheim), the T7-Tag epitope
tag (Novagen Inc.), and glutathione S-transferase (GST) (Pharmacia-LKB Bio-
technology Inc.) were purchased from the indicated suppliers. Antibodies to JIP1
and JIP2 were prepared by immunizing mice with purified bacterially expressed
proteins by standard techniques (8).
Immunofluorescence analysis. Rin5F insulinoma cells were grown on glass
coverslips, washed, and then fixed and permeabilized with methanol at 220°C for
8 min. Indirect immunofluorescence was performed by incubation with 10 mg of
a primary monoclonal antibody to JIP1 or JIP2/ml in 50 mM Tris-Cl (pH
7.4)–150 mM NaCl–3% (wt/vol) bovine serum albumin for 12 h at 4°C. The
secondary antibody was ALEXA 594-conjugated anti-mouse immunoglobulin
(Ig) antibody (1:200; Molecular Probes), and nuclei were visualized by using
SYTOX Green (Molecular Probes). Confocal images were prepared with a Leica
microscope. Double-labeled immunofluorescence images were prepared with a
conventional Zeiss Axiophot microscope by using cells stained with a fluorescein
isothiocyanate-conjugated monoclonal antibody to JIP1 (2.5 mg/ml) and a mono-
clonal antibody to JIP2 (2.5 mg/ml) together with a Texas red-conjugated anti-
mouse Ig secondary antibody (1:100; Jackson Immunoresearch). Nuclei were
detected with 4,6-diamidino-2-phenylindole.
Biochemical assays. Rin5F insulinoma cells and COS-7 cells were cultured in
RPMI medium and Dulbecco modified Eagle medium, respectively, supple-
mented with 10% fetal calf serum (Life Technologies Inc.). Transfection assays
were performed with COS-7 cells by the Lipofectamine method (Life Technol-
ogies Inc.). The cells were solubilized in lysis buffer (20 mM Tris-Cl [pH 7.4], 137
mM NaCl, 2 mM EDTA, 25 mM b-glycerophosphate, 2 mM pyrophosphate, 1
mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 10 mg of leu-
peptin/ml, 10% glycerol, 1% Triton X-100). GST fusion proteins were isolated by
incubation with glutathione-agarose (Pharmacia-LKB Biotechnology Inc.) beads
(20 ml) for 3 h at 4°C. Proteins were immunoprecipitated by incubation for 3 h
at 4°C with antibodies bound to protein G-Sepharose (Pharmacia-LKB Biotech-
nology Inc.). Immunoblot analysis was performed by using enhanced-chemilu-
minescence detection (Kirkegaard & Perry). Binding assays using purified bac-
terially expressed proteins were performed by methods described previously (28).
Protein kinase activity was measured by using the in-gel method with 0.25 mg of
substrate (GST–c-Jun)/ml polymerized in the gel (28).
Nucleotide sequence accession number. The sequence of JIP2 has been de-
posited in GenBank under accession no. AF136382.
RESULTS
Molecular cloning of JIP2. The JIP1 protein has been iden-
tified as a putative scaffold that binds components of the JNK
FIG. 2. Selective binding of JIP1 and JIP2 to the mixed-lineage group of
MAPKKKs. (A) Epitope-tagged JIP1 or JIP2 was expressed in cells together
with epitope-tagged MAPKKKs. Control experiments were performed by trans-
fection of the empty expression vector instead of the JIP expression vector. The
expression of JIP and MAPKKK proteins was examined by immunoblot analysis
of the cell lysates. The MAPKKK proteins were immunoprecipitated with the
M2 monoclonal antibody to the Flag epitope. The presence of JIP proteins in the
immunoprecipitates (IP) was examined by immunoblot analysis using a mono-
clonal antibody that binds the T7-Tag epitope. Coimmunoprecipitation was not
observed in experiments using MEKK1, MEKK3, or MEKK4. In contrast, JIP1
and JIP2 coimmunoprecipitated with the MLKs DLK, MLK2, and MLK3. (B)
The COOH-terminal regions of JIP1 (residues 283 to 660) and JIP2 (residues
499 to 824) were expressed in cells as GST fusion proteins together with epitope-
tagged MLK. Control experiments were performed by transfection with the GST
expression vector pEBG. The amounts of the GST proteins and MLK in the cell
lysates were examined by protein immunoblot analysis. The GST fusion proteins
were precipitated from cell lysates with glutathione-agarose, and MLK present in
the pellet was detected by protein immunoblot analysis.
FIG. 1—Continued.
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signaling pathway (28). We investigated whether additional
members of the JIP group are expressed by mammalian cells.
These studies led to the molecular cloning of human JIP2 (Fig.
1A). The JIP2 gene is composed of 12 exons and is located on
human chromosome 22q13 (Fig. 1B). Sequence analysis of
JIP2 cDNA clones demonstrated the presence of a JNK bind-
ing domain (JBD) in the NH2-terminal region and both an
SH3 domain and a PTB domain in the COOH-terminal region
(Fig. 1C). This domain structure is similar to that of JIP1.
However, unlike JIP1, we obtained no evidence for the expres-
sion of alternatively spliced variants of JIP2 with a deletion in
the PTB domain.
Northern blot analysis of the expression of JIP2 in human
tissues demonstrated that transcripts were detected in the
brain but not in the other tissues examined (Fig. 1D). This
selective expression of JIP2 in the brain differs from JIP1,
which is expressed more widely throughout the body (3). To
directly compare the distribution of these JIP proteins, we
examined the amounts of JIP1 and JIP2 mRNAs in different
human tissues. This analysis demonstrated that both JIP1 and
JIP2 are expressed throughout the nervous system (Fig. 1E).
JIP1 was also expressed in many additional tissues. A low level
of JIP2 expression was also detected in a limited number of
human tissues, including the uterus, prostate, colon, testis,
ovary, pancreas, adrenal gland, thyroid gland, and salivary gland.
The JIP2 scaffold binds components of the JNK cascade.
JIP1 selectively binds components of the JNK signaling path-
way (28). We therefore examined the interaction of JIP2 with
MAPKKKs, MAPKKs, and MAPKs.
The interaction of JIP1 and JIP2 with MAPKKKs was ex-
amined in coimmunoprecipitation assays (Fig. 2). The JIP pro-
teins did not bind members of the MEKK group, for example,
MEKK1 and MEKK4 (Fig. 2A). However, a very small amount
of coimmunoprecipitation of MEKK3 was detected in experi-
ments using JIP1 but not JIP2 (Fig. 2A). Furthermore, a very
small amount of coimmunoprecipitation of the MAPKKK
ASK1 with both JIP1 and JIP2 was detected (data not shown).
In contrast, three different MLKs (DLK, MLK2, and MLK3)
coimmunoprecipitated with JIP1 and JIP2 (Fig. 2A). Recipro-
cal precipitation-immunoblot analysis confirmed the interac-
tion between the JIP proteins and MLKs (Fig. 2B). These data
demonstrated that both JIP1 and JIP2 selectively interact with
the MLK group of MAPKKKs. The COOH-terminal region of
JIP1 (28) or JIP2 (Fig. 2B) was sufficient for the observed
interaction with MLK3.
Coimmunoprecipitation assays were performed to investi-
gate the interaction of JIP proteins with MAPKKs (Fig. 3). No
evidence for interaction with JIP1 or JIP2 was obtained in
experiments using activators of the ERK (MEK1) or p38
MAPK (MKK3 and MKK6) pathways (Fig. 3A). Similarly,
MKK4, an activator of JNK, did not coimmunoprecipitate with
the JIP proteins. However, both JIP1 and JIP2 were found to
coimmunoprecipitate with the JNK activator MKK7 (Fig. 3A).
The interaction of MKK7 with the JIP proteins was confirmed
by reciprocal precipitation-immunoblot analysis (Fig. 3B).
Thus, both JIP1 and JIP2 selectively bind the MAPKK isoform
MKK7. The COOH-terminal region of JIP1 (28) or JIP2 (Fig.
3B) was sufficient for the observed interaction with MKK7.
To test the interaction of the JIP proteins with MAPKs, we
performed coimmunoprecipitation assays with JNK, ERK, and
p38 MAPK (Fig. 4). These experiments demonstrated that
ERK and p38 MAPK did not interact with JIP1 or JIP2 pro-
teins. In contrast, both JIP proteins coimmunoprecipitated
with JNK (Fig. 4A). Reciprocal precipitation-immunoblot
analysis confirmed that JNK interacts with JIP proteins (Fig.
4B). These data demonstrate that JIP1 and JIP2 selectively
bind the JNK group of MAPKs. The NH2-terminal region of
JIP1 (28) or JIP2 (Fig. 4B) was sufficient for the observed
interaction with JNK.
Comparison of JIP1 and JIP2 indicates that these proteins
exhibit similar binding properties in assays using MAPKKKs
and MAPKKs (Fig. 2 and 3). In contrast, the interaction with
MAPKs appears to differ between JIP1 and JIP2. While both
JIP proteins selectively bind JNK, a greater amount of JNK bind-
ing to JIP1 than to JIP2 was detected (Fig. 4A and B). To quan-
titate this difference and to examine the relative binding to dif-
ferent JNK isoforms, we performed assays using JNK prepared by
in vitro translation in the presence of [35S]methionine. The bind-
ing of JNK isoforms to immobilized recombinant JIP1 and JIP2
was examined (Fig. 4C). These experiments demonstrated that
10 different JNK isoforms bound to both JIP proteins. How-
ever, differences in binding were detected. First, the amount of
JNK binding to JIP1 was markedly greater than the binding to
JIP2. Second, some JNK isoforms (e.g., JNK1a1) were found
to bind JIP more strongly than other JNK isoforms (e.g.,
JNK2a2). These data indicate that JIP proteins interact with
JNK and can distinguish between JNK isoforms.
To test whether the interaction of JIP2 with JNK, MKK7,
and MLK3 might be direct, we investigated the binding of JIP2
to these protein kinases using purified bacterially expressed
recombinant proteins. This analysis demonstrated that JIP2
FIG. 3. Selective binding of JIP1 and JIP2 to the MAPKK MKK7. (A)
Epitope-tagged JIP1 and JIP2 were expressed in cells together with epitope-
tagged MEK1, MKK3, MKK4, MKK6, or MKK7. Control experiments were
performed by transfection of the empty expression vector instead of the JIP
expression vector. The expression of JIP and MAPKK proteins was examined by
immunoblot analysis of the cell lysates. The MAPKK proteins were immunopre-
cipitated, and the presence of JIP1 and JIP2 in the immunoprecipitates (IP) was
examined by immunoblot analysis using a monoclonal antibody that binds the
T7-Tag epitope. (B) The COOH-terminal regions of JIP1 (residues 283 to 660)
and JIP2 (residues 499 to 824) were expressed in cells as GST fusion proteins
together with epitope-tagged MKK7. Control experiments were performed by
transfection with the GST expression vector pEBG. The amounts of the GST
proteins and MKK7 in the cell lysates were examined by protein immunoblot
analysis. The GST fusion proteins were precipitated from cell lysates with glu-
tathione-agarose, and MKK7 present in the pellet was detected by protein
immunoblot analysis using an antibody to the Flag epitope.
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binds to JNK, MKK7, and MLK3 (Fig. 5). Similarly, purified
recombinant JIP1 binds to purified recombinant JNK, MKK7,
and MLK3 (28).
JIP2 regulates signal transduction by the JNK signaling
pathway. The binding to MLKs, MKK7, and JNK suggests that
JIP2 may act as a scaffold protein. We therefore examined the
effect of JIP2 overexpression on the JNK signal transduction
pathway. Initial studies of the effect of JIP2 overexpression
indicated that JIP2, like JIP1, acted as a powerful inhibitor of
JNK signaling. For example, studies of the chimeric transcrip-
tion factor GAL4–ATF-2 demonstrated that both JIP1 and
JIP2 inhibited JNK-dependent reporter gene expression by
more than 90% (data not shown). This inhibition of JNK sig-
naling by JIP proteins (3) is probably mediated by the seques-
tration of limiting components of the JNK signaling pathway into
separate complexes by the overexpressed scaffold protein (28).
To test the effect of JIP2 under conditions where sequestra-
tion of limiting components of the JNK signaling pathway does
not occur, we coexpressed JIP proteins with components of the
JNK signaling pathway (Fig. 6). JNK activity was measured in
an in vitro protein kinase assay using recombinant c-Jun as the
substrate. This analysis demonstrated that MLK3 caused JNK
activation. Expression of JIP1 and JIP2 enhanced the activa-
tion of JNK caused by MLK3. Similar data were obtained in
experiments using JNK1, JNK2, or JNK3. Together, these data
demonstrated that JIP2 increases JNK activation by the MLK
signaling pathway. The effect of JIP2 in increasing JNK acti-
vation was similar to that caused by JIP1.
FIG. 4. Selective binding of JIP1 and JIP2 to the JNK group of MAPKs. (A) Epitope-tagged (T7-Tag) JIP1 and JIP2 were expressed in cells with the HA-tagged
MAPKs ERK2, p38a, and JNK2a2. Control experiments were performed by transfection of the empty expression vector instead of the JIP expression vectors. The
MAPKs were immunoprecipitated with an antibody to HA. The presence of JIP in the immunoprecipitates (IP) was detected on immunoblots probed with an antibody
to T7-Tag. The amounts of JIP and MAPKs in the cell lysates were examined by protein immunoblot analysis. (B) The NH2-terminal regions of JIP1 (residues 1 to 282)
and JIP2 (residues 1 to 229) were expressed in cells as GST fusion proteins together with epitope-tagged JNK1a1 or JNK2a2. Control experiments were performed
by transfection with the GST expression vector pEBG instead of the JIP expression vector. The amounts of the GST fusion proteins and JNK in the cell lysates were examined
by protein immunoblot analysis. The GST fusion proteins were precipitated from cell lysates with glutathione-agarose, and JNK present in the pellet was detected by protein
immunoblot analysis using an antibody to the HA epitope. (C) Comparison of the binding of 10 human JNK isoforms to JIP1 and JIP2. The JNK protein kinases were prepared
by in vitro translation in the presence of [35S]methionine. The JNK proteins were incubated with GST-JIP1, GST-JIP2, or GST immobilized on glutathione-agarose beads.
The beads were washed with lysis buffer. Bound JNK was detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. The amount of
JNK bound was quantitated by PhosphorImager analysis. The data are presented graphically as relative binding by defining the amount of JNK1a1 binding to JIP1 as 1.0.
FIG. 5. JIP2 binds JNK, MKK7, and MLK3 in vitro. Purified bacterially
expressed GST and GST-JIP2 fusion proteins were immobilized on glutathione-
agarose and incubated with purified bacterially expressed JNK2, MKK7, or
MLK3 (residues 1 to 204). Bound JNK2, MKK7, and MLK3 were detected by
immunoblot analysis.
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Coexpression of JIP1 with JIP2 did not cause further en-
hancement of JNK activation beyond that caused by either
JIP1 or JIP2 alone (Fig. 6). Since the binding of JNK to JIP1
was markedly greater than the binding of JNK to JIP2 (Fig. 4),
the similar effects of JIP1 and JIP2 on JNK activation (Fig. 6)
suggest that the function of JIP proteins to potentiate MLK-
stimulated JNK activation may be catalytic and may not re-
quire the formation of stable complexes with JNK.
JNK scaffold complexes are formed by JIP1 and JIP2. JIP1
and JIP2 are individually capable of forming scaffold com-
plexes for the MLK3MKK73JNK signaling pathway. How-
ever, both JIP1 and JIP2 are expressed in the brain (Fig. 1).
This coexpression of JIP1 and JIP2 raises questions about
whether the JIP1 and JIP2 scaffold complexes are independent
or whether these complexes may interact. To examine this
question, we performed coimmunoprecipitation analysis of
JIP1 and JIP2 (Fig. 7). These experiments demonstrated that
JIP1 interacts with JIP2. Furthermore, both JIP1 and JIP2
were observed to self-associate. These data indicated that JIP1
and JIP2 can form both homo-oligomers and hetero-oli-
gomers. Deletion analysis demonstrated that the COOH-ter-
minal regions of JIP1 and JIP2 were sufficient for the forma-
tion of hetero-oligomeric complexes (Fig. 8).
To examine whether JIP1 and JIP2 form oligomeric com-
plexes in vivo, we prepared antibodies to JIP1 and JIP2 (Fig.
9A). These antibodies detect endogenous JIP1 and JIP2 pro-
teins expressed by cultured cells (Fig. 9B). Reciprocal immu-
noprecipitation-immunoblot analysis of cell extracts demon-
strated coprecipitation of JIP1 and JIP2 (Fig. 9B). These data
confirm the observation made with transfected recombinant
JIP proteins in cultured cells by demonstrating an interaction
between the endogenous JIP proteins in vivo.
Subcellular localization of JIP scaffold complexes. We in-
vestigated the subcellular localization of JIP proteins using
monoclonal antibodies to JIP1 and JIP2. Confocal immuno-
fluorescence microscopy demonstrated that both JIP1 and
JIP2 were located in the cytoplasm and were largely excluded
from the nucleus (Fig. 10A). This distribution of JIP proteins
was unaffected when JNK was activated following treatment of
the cells with interleukin-1 or exposure to UV-C radiation
FIG. 6. JIP1 and JIP2 enhance JNK activation by MLK3. Epitope-tagged
(HA) JNK1a1 (A), JNK2a2 (B), and JNK3a2 (C) were each expressed alone or
coexpressed with JIP1 and/or JIP2. JNK activity was examined by using c-Jun as
a substrate. The effect of coexpression with MLK3 was examined. The amounts
of JIP, MLK, and JNK expressed were examined by immunoblot analysis.
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(data not shown). Comparison of JIP1 and JIP2 indicated that
the patterns of expression of these proteins differed. Immuno-
fluorescence analysis demonstrated a punctate appearance of
JIP1 in the cytoplasm and an accumulation of JIP1 in cell
surface projections (Fig. 10A). A similar punctate expression
of JIP2 was observed, but more extensive cytoplasmic accumu-
lation of JIP2 than JIP1 was detected.
To compare the distribution of JIP1 and JIP2, we performed
double-label immunofluorescence analysis (Fig. 10B). JIP1
and JIP2 colocalized in the peripheral cell surface projections where most of the JIP1 protein was detected. In addition, the
punctate cytoplasmic distributions of JIP1 and JIP2 were sim-
ilar. However, the majority of JIP2 was found in cytoplasmic
structures that did not appear to contain JIP1. Thus, some JIP2
molecules colocalize with JIP1 (Fig. 10B). This conclusion is
consistent with the observation that a fraction of the total JIP2
molecules coimmunoprecipitated with JIP1 (Fig. 9B). To-
gether, these data indicate that the JIP1 and JIP2 scaffolds
exist in vivo as both homo- and hetero-oligomeric complexes.
DISCUSSION
Two members of the JIP group have been identified: JIP1 (1,
3, 13) and JIP2 (Fig. 1). These JIP proteins are related in
structure (Fig. 1), but the genes that encode these proteins are
not closely linked in the genome. The human JIP1 gene is
located on human chromosome 11 (11p11.2-p12), while a JIP1
pseudogene is located on human chromosome 17 (17q21) (16).
In contrast, the JIP2 gene is located on human chromosome 22
(22q13) (Fig. 1). Comparison of the expression of the JIP1 and
JIP2 genes indicates that both JIP proteins are widely ex-
pressed in many regions of the brain (Fig. 1). In addition,
expression of JIP1 and JIP2 was detected in other tissues.
The JIP1 and JIP2 proteins interact with multiple compo-
nents of the JNK signaling pathway, including the JNK group
of MAPKs, the MAPKK isoform MKK7, and members of the
MLK group of MAPKKKs (Fig. 2 to 4). Functional analysis
demonstrated that these complexes cause marked potentiation
of JNK activation (Fig. 6). These data suggest that the JIP1 and
JIP2 proteins act as molecular scaffolds that mediate the acti-
vation of the JNK signaling pathway in vivo.
The JIP scaffold proteins were found to self-associate to
form intermolecular complexes (Fig. 7). Coimmunoprecipita-
FIG. 7. JIP proteins form homo- and hetero-oligomeric scaffold complexes.
Epitope-tagged JIP1 and JIP2 proteins (Flag and T7-Tag) were expressed in
COS-7 cells. The expression of epitope-tagged JIP proteins was examined by
immunoblot analysis of cell lysates with antibodies to Flag and T7-Tag. Coim-
munoprecipitation analysis was performed by immunoblot analysis (T7-Tag an-
tibody) of immunoprecipitates (IP) prepared by using the M2 monoclonal anti-
body to the Flag epitope.
FIG. 8. The interaction of JIP1 and JIP2 is mediated by the COOH-terminal
region. Epitope-tagged JIP1 was expressed in COS-7 cells together with GST or
GST-JIP2 fusion proteins. The expression of JIP1 was detected by immunoblot
analysis using an antibody to the T7 epitope tag. GST and GST-JIP2 fusion
proteins were detected by immunoblot analysis using an antibody that binds
GST. The interaction of JIP1 with JIP2 was examined by isolation of GST and
GST-JIP2 complexes using glutathione-agarose and immunoblot analysis of the
bound T7-tagged JIP1. Deletion analysis demonstrated that the COOH-terminal
regions, but not the NH2-terminal regions, of JIP1 and JIP2 were sufficient for
the formation of hetero-oligomeric complexes.
FIG. 9. Identification of endogenous oligomeric JIP complexes. (A) Charac-
terization of monoclonal antibodies to JIP1 and JIP2. COS-7 cell lysates con-
taining T7-Tag-labeled JIP proteins were examined by protein immunoblot anal-
ysis using antibodies to the T7-Tag and monoclonal antibodies to JIP1 and JIP2.
(B) JIP1 and JIP2 interact in vivo. Extracts were prepared from Rin5F insuli-
noma cells and examined by protein immunoblot analysis by probing with murine
antibodies to JIP1 and JIP2. The endogenous JIP1 and JIP2 proteins were
detected in the cell lysates and in immunoprecipitates (IP) prepared by using
antibodies to JIP1 and JIP2.
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tion studies demonstrated the presence of both homo- and
hetero-oligomeric complexes. These oligomeric JIP complexes
may contribute to the scaffold function of JIP proteins by
aggregating components of the JNK signaling pathway to cre-
ate a functional protein kinase cascade. This oligomeric struc-
ture of JIP is analogous to the Ste5p scaffold protein in yeast,
which also forms oligomeric complexes containing more than
one Ste5p molecule (5, 10, 33).
Previous studies of overexpressed epitope-tagged JIP1 indi-
cate that it is located exclusively in the cytoplasm (3). Similarly,
overexpressed epitope-tagged JIP2 was also detected in the
cytoplasm (data not shown). Together, these observations sug-
gest that the endogenous JIP proteins expressed by cells may
also be located in the cytoplasm. To examine this question, we
prepared monoclonal antibodies to JIP1 and JIP2 and exam-
ined the distribution of the endogenous JIP proteins in
cultured cells (Fig. 10). These data confirmed that both JIP
proteins were detected in the cytoplasm. Interestingly, the
majority of the JIP1 protein accumulated in peripheral cyto-
plasmic projections that extend from the cell surface. The JIP2
protein colocalized in these cell surface projections but was
also found to accumulate in a cytoplasmic compartment that
did not include JIP1. It is tempting to speculate that the ob-
served cell surface location of JIP proteins may represent a site
of action of these scaffold proteins in vivo, as described for the
yeast scaffold protein Ste5p (18).
In a recent study, JIP1 was implicated in the expression of
the Glut2 and insulin genes (1). Further studies are required to
determine whether there is a similar role for JIP2. The JIP1
function of regulating Glut2 and insulin gene expression was
proposed to be mediated by nuclear JIP1 (1). Our immuno-
fluorescence analysis of endogenous JIP proteins did not de-
tect significant amounts of nuclear JIP1 or JIP2. We cannot
eliminate the possibility that JIP proteins might accumulate in
the nucleus under some experimental conditions. However, it
is possible that the effect of JIP1 on Glut2 and insulin gene
expression may be indirectly mediated by changes in JNK ac-
tivity (or some other JIP-regulated activity).
FIG. 10. Cytoplasmic location of endogenous JIP proteins. (A) The endogenous JIP1 and JIP2 proteins expressed by Rin5F insulinoma cells were detected by
confocal immunofluorescence analysis using monoclonal antibodies to JIP1 and JIP2 (red). The nucleus was detected by staining DNA with SYTOX green. (B)
Double-label immunofluorescence analysis of JIP1 (green) and JIP2 (red) was performed by conventional microscopy. The nucleus was detected by staining DNA with
4,6-diamidino-2-phenylindole (blue).
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The JIP group of MAPK scaffold proteins includes at least
two members. Both JIP1 and JIP2 strongly potentiate JNK
activation by the MLK/MKK7 signaling pathway. The function
of the JIP scaffold proteins appears similar to that of the Ste5p
scaffold, which mediates activation of the Ste11p (MAPKKK),
Ste7p (MAPKK), and Fus3p (MAPK) signaling pathway in
yeast (for a review, see reference 29). The results of the present
study demonstrate that JIP proteins exist as oligomers in vivo
and are detected in peripheral cell surface projections. These
properties are similar to those of the yeast Ste5p scaffold,
which also functions as an oligomer (5, 10, 33) and is present
in pheromone-induced cell projections (18). Together, these
data suggest that mammalian JIP and yeast Ste5p may function
by analagous mechanisms that involve the selective aggrega-
tion of MAPK pathway components in a discrete cellular com-
partment.
The JIP scaffold proteins interact with MLKs, MKK7, and
JNK. Interactions with other components of the JNK signaling
pathway, including MKK4 and members of the MEKK group
of MAPKKKs, were not observed. This selectivity indicates
that JIP scaffold complexes represent only one mechanism of
JNK activation. Signals mediated by MEKK protein kinases
and MKK4 function independently of the JIP scaffold com-
plexes (29). These signals may be mediated by other scaffold
complexes. Alternatively, JNK may be activated by a mecha-
nism involving intermolecular associations between signaling
components, as described recently for signaling mediated by
MEKK1 (27, 30, 32). The concept that scaffold-dependent and
scaffold-independent signaling pathways can coexist has been
established by studies of MAPK signaling in yeast (for a re-
view, see reference 29). An important goal for future research
will be to define the relative roles of these alternative mecha-
nisms that mediate JNK activation. The analysis of mice with
targeted disruptions of genes that encode components of the
JNK signaling pathway will facilitate the genetic dissection of
these processes.
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